ArticleScientific reports2018

Development of a Novel Backbone Cyclic Peptide Inhibitor of the Innate Immune TLR/IL1R Signaling Protein MyD88.

Shira Dishon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.